Iterum Therapeutics PLC (ITRM)
1.10
-0.04
(-3.51%)
USD |
NASDAQ |
Jun 08, 16:00
1.10
0.00 (0.00%)
After-Hours: 20:00
Iterum Therapeutics Cash from Investing (TTM): 9.47M for March 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2023 | 9.47M |
December 31, 2022 | 13.96M |
September 30, 2022 | 5.113M |
June 30, 2022 | -5.799M |
March 31, 2022 | -11.08M |
December 31, 2021 | -54.60M |
September 30, 2021 | -50.13M |
June 30, 2021 | -55.07M |
March 31, 2021 | -33.93M |
December 31, 2020 | -0.011M |
September 30, 2020 | -0.013M |
Date | Value |
---|---|
June 30, 2020 | 0.021M |
March 31, 2020 | 5.011M |
December 31, 2019 | 40.10M |
September 30, 2019 | 68.85M |
June 30, 2019 | 51.05M |
March 31, 2019 | 17.08M |
December 31, 2018 | -8.658M |
September 30, 2018 | -30.96M |
June 30, 2018 | -16.82M |
March 31, 2018 | -21.71M |
December 31, 2017 | -31.59M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-55.07M
Minimum
Jun 2021
68.85M
Maximum
Sep 2019
-2.821M
Average
-0.012M
Median
Cash from Investing (TTM) Benchmarks
Alkermes PLC | 68.95M |
Jazz Pharmaceuticals PLC | -413.76M |
Perrigo Co PLC | -2.041B |
Horizon Therapeutics PLC | -135.03M |
Mallinckrodt PLC | -- |